T2 Biosystems, Inc.
TTOODelisted Jul 10, 2025- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001492674
T2 Biosystems, Inc. was delisted on Jul 10, 2025; its insiders filed their last Form 4 on Jan 2, 2025; 1 institution reported holding it in 13F filings for Q2 2025, worth $0 in total; no superinvestor held it.
Q3 2024 vs. Q2 2024
How the institutions holding T2 Biosystems, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 21 | 2 | 21 | +2 |
| Shares | 2.35M | 78.3K | 2.15M | −120.5K (−5.3%) |
| Value | $12.6M | $418.2K | $4.24M | −$7.89M (−65.1%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (3)
Institutions that held T2 Biosystems, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 76,827 | $151.3K | 0.00% |
| Millennium Management LLC | 39,140 | $77.1K | 0.00% |
| Barclays PLC | 101 | $199 | 0.00% |
Sold out (1)
Institutions that held T2 Biosystems, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| JPMorgan Chase & Co | 15 | $80 |
Not filed for Q3 2024 yet (2)
Institutions that held T2 Biosystems, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 78,298 | $418.1K |
| JJJ Advisors Inc. | 9 | $49 |